{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T06:07:40Z","timestamp":1768457260700,"version":"3.49.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["dldjournalonline.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Digestive and Liver Disease"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/j.dld.2015.12.012","type":"journal-article","created":{"date-parts":[[2015,12,29]],"date-time":"2015-12-29T02:00:25Z","timestamp":1451354425000},"page":"441-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study"],"prefix":"10.1016","volume":"48","author":[{"given":"Bertrand","family":"Brieau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Auzolle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Astrid","family":"Pozet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Tougeron","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivier","family":"Bouch\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pauline","family":"Soibinet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Romain","family":"Coriat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caroline","family":"Prieux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thierry","family":"Lecomte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gael","family":"Goujon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lysiane","family":"Marthey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philippe","family":"Rougier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Franck","family":"Bonnetain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michel","family":"Ducreux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julien","family":"Taieb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aziz","family":"Zaanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.dld.2015.12.012_bib0165","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1016\/S0140-6736(14)62038-9","article-title":"Global surveillance of cancer survival 1995\u20132009: analysis of individual data for 25676887 patients from 279 population-based registries in 67 countries (CONCORD-2)","volume":"385","author":"Allemani","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.dld.2015.12.012_bib0170","first-page":"69","article-title":"Global cancer statistics","volume":"61","author":"Jemal","year":"2011","journal-title":"CA: A Cancer Journal for Clinicians"},{"key":"10.1016\/j.dld.2015.12.012_bib0175","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/0002-9378(73)90125-7","article-title":"Classic pages in obstetrics and gynecology: Friedrich Ernst Krukenberg: Fibrosarcoma ovarii mucocellulare (carcinomatodes). Archiv fur Gynakologie, vol. 50, pp. 287\u2013321, 1896","volume":"117","year":"1973","journal-title":"American Journal of Obstetrics & Gynecology"},{"key":"10.1016\/j.dld.2015.12.012_bib0180","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.ygyno.2003.12.039","article-title":"Incidence of metastasis to the ovaries from nongenital tract primary tumors","volume":"93","author":"Moore","year":"2004","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0185","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1097\/01.pas.0000190787.85024.cb","article-title":"Krukenberg tumors of the ovary: a clinicopathologic analysis of 120 cases with emphasis on their variable pathologic manifestations","volume":"30","author":"Kiyokawa","year":"2006","journal-title":"American Journal of Surgical Pathology"},{"key":"10.1016\/j.dld.2015.12.012_bib0190","first-page":"241","article-title":"Metastatic ovarian tumors: a clinicopathologic study of 150 cases","volume":"35","author":"Alvarado-Cabrero","year":"2013","journal-title":"Analytical and Quantitative Cytology and Histology"},{"key":"10.1016\/j.dld.2015.12.012_bib0195","first-page":"221","article-title":"Krukenberg tumor of the ovaries. A review of 81 records","volume":"32","author":"Hale","year":"1968","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.dld.2015.12.012_bib0200","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s101470300012","article-title":"Clinical and pathological study of gastric cancer with ovarian metastasis","volume":"8","author":"Kobayashi","year":"2003","journal-title":"International Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0205","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ygyno.2005.05.028","article-title":"The role of cytoreductive surgery in nongenital cancers metastatic to the ovaries","volume":"98","author":"Ayhan","year":"2005","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0210","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.ejso.2008.05.006","article-title":"Surgical treatment for patients with different origins of Krukenberg tumors: outcomes and prognostic factors","volume":"35","author":"Jiang","year":"2009","journal-title":"European Journal of Surgical Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0215","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1006\/gyno.2001.6210","article-title":"Prognostic factors of Krukenberg's tumor","volume":"82","author":"Kim","year":"2001","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0220","doi-asserted-by":"crossref","first-page":"2903","DOI":"10.1200\/JCO.2005.05.0245","article-title":"Chemotherapy in advanced gastric cancer: a systematic review and meta-analysis based on aggregate data","volume":"24","author":"Wagner","year":"2006","journal-title":"Journal of Clinical Oncology"},{"issue":"Suppl 6","key":"10.1016\/j.dld.2015.12.012_bib0225","doi-asserted-by":"crossref","first-page":"vi57","DOI":"10.1093\/annonc\/mdt344","article-title":"Gastric cancer: ESMO-ESSO-ESTRO Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"24","author":"Waddell","year":"2013","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0230","first-page":"CD004064","article-title":"Chemotherapy for advanced gastric cancer","author":"Wagner","year":"2010","journal-title":"Cochrane Database Systematic Review"},{"key":"10.1016\/j.dld.2015.12.012_bib0235","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1200\/JCO.2007.13.9378","article-title":"Phase III trial in metastatic gastroesophageal adenocarcinoma with fluorouracil, leucovorin plus either oxaliplatin or cisplatin: a study of the Arbeitsgemeinschaft Internistische Onkologie","volume":"26","author":"Al-Batran","year":"2008","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0240","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1056\/NEJMoa073149","article-title":"Capecitabine and oxaliplatin for advanced esophagogastric cancer","volume":"358","author":"Cunningham","year":"2008","journal-title":"New England Journal of Medicine"},{"key":"10.1016\/j.dld.2015.12.012_bib0245","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1200\/JCO.2013.54.1011","article-title":"Prospective, randomized, multicenter, phase III study of fluorouracil, leucovorin, and irinotecan versus epirubicin, cisplatin, and capecitabine in advanced gastric adenocarcinoma: a French intergroup study","volume":"32","author":"Guimbaud","year":"2014","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0250","doi-asserted-by":"crossref","first-page":"4991","DOI":"10.1200\/JCO.2006.06.8429","article-title":"Phase III study of docetaxel and cisplatin plus fluorouracil compared with cisplatin and fluorouracil as first-line therapy for advanced gastric cancer: a report of the V325 Study Group","volume":"24","author":"Van Cutsem","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0255","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1093\/annonc\/mdn403","article-title":"Biweekly fluorouracil, leucovorin, oxaliplatin, and docetaxel (FLOT) for patients with metastatic adenocarcinoma of the stomach or esophagogastric junction: a phase II trial of the Arbeitsgemeinschaft Internistische Onkologie","volume":"19","author":"Al-Batran","year":"2008","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0260","first-page":"26","article-title":"Docetaxel plus oxaliplatin with or without fluorouracil or capecitabine in metastatic or locally recurrent gastric cancer: a randomized phase II study","author":"Van Cutsem","year":"2015","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0265","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1093\/jnci\/92.3.205","article-title":"New guidelines to evaluate the response to treatment in solid tumors. European Organization for Research and Treatment of Cancer, National Cancer Institute of the United States, National Cancer Institute of Canada","volume":"92","author":"Therasse","year":"2000","journal-title":"Journal of the National Cancer Institute"},{"key":"10.1016\/j.dld.2015.12.012_bib0270","first-page":"391","article-title":"Cancer metastatic to the ovary: factors influencing survival","volume":"45","author":"Webb","year":"1975","journal-title":"Obstetrics and Gynecology"},{"key":"10.1016\/j.dld.2015.12.012_bib0275","first-page":"427","article-title":"[Krukenberg tumors. Analysis of a series of 28 cases]","volume":"133","author":"Savey","year":"1996","journal-title":"Journal de chirurgie"},{"key":"10.1016\/j.dld.2015.12.012_bib0280","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1016\/j.ejso.2008.03.010","article-title":"The differential response to chemotherapy of ovarian metastases from colorectal carcinoma","volume":"34","author":"Goere","year":"2008","journal-title":"European Journal of Surgical Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0285","doi-asserted-by":"crossref","first-page":"3194","DOI":"10.1200\/JCO.2003.02.153","article-title":"Phase III trial of carboplatin and paclitaxel compared with cisplatin and paclitaxel in patients with optimally resected stage III ovarian cancer: a Gynecologic Oncology Group study","volume":"21","author":"Ozols","year":"2003","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0290","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S1470-2045(14)70049-X","article-title":"Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial","volume":"15","author":"Pignata","year":"2014","journal-title":"Lancet Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0295","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1093\/annonc\/mdf034","article-title":"Clinical determinants of survival in patients with 5-fluorouracil-based treatment for metastatic colorectal cancer: results of a multivariate analysis of 3825 patients","volume":"13","author":"Kohne","year":"2002","journal-title":"Annals of Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0300","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1200\/JCO.2005.03.0106","article-title":"OPTIMOX1: a randomized study of FOLFOX4 or FOLFOX7 with oxaliplatin in a stop-and-Go fashion in advanced colorectal cancer \u2013 a GERCOR study","volume":"24","author":"Tournigand","year":"2006","journal-title":"Journal of Clinical Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0305","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/s10120-014-0442-3","article-title":"Prognostic factors in metastatic gastric cancer: results of a population-based, retrospective cohort study in Ontario","volume":"19","author":"Dixon","year":"2014","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.dld.2015.12.012_bib0310","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1007\/s10120-011-0083-8","article-title":"Reporting patient characteristics and stratification factors in randomized trials of systemic chemotherapy for advanced gastric cancer","volume":"15","author":"Shitara","year":"2012","journal-title":"Gastric Cancer"},{"key":"10.1016\/j.dld.2015.12.012_bib0315","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.ygyno.2004.05.007","article-title":"Survival benefit of metastasectomy for Krukenberg tumors from gastric cancer","volume":"94","author":"Cheong","year":"2004","journal-title":"Gynecologic Oncology"},{"key":"10.1016\/j.dld.2015.12.012_bib0320","first-page":"3397","article-title":"Metastasectomy of Krukenberg tumors may be associated with survival benefits in patients with metastatic gastric cancer","volume":"32","author":"Lu","year":"2012","journal-title":"Anticancer Research"}],"container-title":["Digestive and Liver Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815007264?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1590865815007264?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T10:52:38Z","timestamp":1537095158000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1590865815007264"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,4]]},"references-count":32,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S1590865815007264"],"URL":"https:\/\/doi.org\/10.1016\/j.dld.2015.12.012","relation":{},"ISSN":["1590-8658"],"issn-type":[{"value":"1590-8658","type":"print"}],"subject":[],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of modern chemotherapy and prognostic factors in patients with ovarian metastases from gastric cancer: A retrospective AGEO multicentre study","name":"articletitle","label":"Article Title"},{"value":"Digestive and Liver Disease","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.dld.2015.12.012","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Editrice Gastroenterologica Italiana S.r.l. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}